Pricing model
Healthcare toolsLunit’s medical AI software, INSIGHT and SCOPE, enable doctors to detect cancer earlier and predict treatment outcomes more accurately, improving the chances of successful treatment and recovery.
Description
Lunit is a publicly traded organization that specializes in developing cutting-edge medical AI software that is specifically designed to help conquer cancer. It is widely known that early detection plays a pivotal role in a cancer patient’s prognosis and outcome, and this is where Lunit’s cancer screening AI comes into play. Lunit INSIGHT is a medical technology tool that utilizes AI to enable doctors to detect cancer earlier, with remarkable clarity and accuracy. This AI-driven tool can accurately detect abnormal radiological results in up to 97-99% of cases/mammograms, even anomalies that would be subtle or invisible to the human eye and missed by trained medical personnel without the help of Lunit’s AI assistance. This screening tool is incredibly effective in detecting early warning signs of cancer and improves the chances of successful treatment and recovery.
In addition to INSIGHT, Lunit’s SCOPE is an AI-powered tool that predicts treatment responses in cancer patients. With this technology, doctors can make informed decisions about treating their patients based on the predicted outcomes. This way, patients can receive the most effective and personalized care possible. SCOPE combines data from previous patient responses to treatments, and applies AI models to identify patterns and predictions. This approach helps physicians recommend personalized treatment strategies that are based upon a patient’s history, health profile, and medical factors.
All in all, Lunit’s two AI-powered tools, INSIGHT and SCOPE, represent a significant leap forward in the way cancer care is delivered. With the potential to catch cancer in its earliest stages, and to provide personalized treatment options, Lunit represents a tangible hope and promise for cancer patients and healthcare providers alike.
There are no reviews yet.